American International Group, Inc. Spruce Biosciences, Inc. Transaction History

American International Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.28 - $2.23 $5,519 - $9,615	-4,312 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.85 - $4.59 $560 - $1,390	-303 Reduced 6.57%	4,312 $9,000
Q4 2021 Feb 11, 2022	SELL	$2.33 - $5.74 $321 - $792	-138 Reduced 2.9%	4,615 $21,000
Q3 2021 Nov 12, 2021	SELL	$6.01 - $11.26 $679 - $1,272	-113 Reduced 2.32%	4,753 $29,000
Q2 2021 Aug 13, 2021	BUY	$10.12 - $17.46 $8,156 - $14,072	806 Added 19.85%	4,866 $55,000
Q1 2021 May 07, 2021	BUY	$14.8 - $25.79 $148 - $257	10 Added 0.25%	4,060 $67,000
Q4 2020 Feb 12, 2021	BUY	$15.38 - $32.42 $62,289 - $131,301	4,050 New	4,050 $98,000

15.9M

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $9.9M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.